About Ognomy
Ognomy is a company based in New York (United States) founded in 2001 by Daniel Rifkin. Ognomy has raised $21.58 million across 3 funding rounds from investors including Inspire Medical, Impellent Ventures and Catalyst Investors. Ognomy offers products and services including Video Consultation Service, Home Sleep Test, and Personalized Treatment Plan. Ognomy operates in a competitive market with competitors including Stellar Sleep, Rise, Loona, GEM Health and Nox Health, among others.
- Headquarter New York, United States
- Founders Daniel Rifkin
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ognomy, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$21.58 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series A
May 18, 2026
-
Investors
Inspire Medical
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ognomy
Ognomy offers a comprehensive portfolio of products and services, including Video Consultation Service, Home Sleep Test, and Personalized Treatment Plan.
Enables remote consultations with sleep specialists for diagnosis.
At-home device for detecting sleep apnea through overnight monitoring.
Customized plans including CPAP and lifestyle advice for sleep care.
People of Ognomy
Unlock access to complete
Unlock access to complete
Funding Insights of Ognomy
Ognomy has successfully raised a total of $21.58M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ognomy
Ognomy has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Inspire Medical, Impellent Ventures and Catalyst Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital funding is provided by Impellent Ventures.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Ognomy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ognomy
Investment portfolio details for Ognomy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ognomy
Detailed financials for Ognomy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ognomy Comparisons
Peer comparison for Ognomy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ognomy
Ognomy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stellar Sleep, Rise, Loona, GEM Health and Nox Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sleep quality is monitored through a specialized application.
|
|
| Locked | Locked | Locked |
Marketing and branding services are offered by RISE.
|
|
| Locked | Locked | Locked |
Provider of an app for insomnia issue
|
|
| Locked | Locked | Locked |
Digital tools and support for sleep apnea treatment are provided.
|
|
| Locked | Locked | Locked |
Provider of a sleep enhancement platform for employees, individuals, and healthcare provides
|
Detailed competitors of Ognomy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ognomy
Complete news archive for Ognomy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ognomy
Ognomy was founded in 2001 and raised its 1st funding round 21 years after it was founded.
Ognomy is headquartered in New York, United States. It is registered at New York, New York, United States.
Daniel Rifkin is the current CEO of Ognomy. They have also founded this company.
Ognomy is a funded company, having raised a total of $21.58M across 3 funding rounds to date.
Ognomy was founded in 2001 in New York, United States, as an online platform in the telemedicine sector. Video consultations with doctors are facilitated for sleep apnea management. Sleep tests are conducted from patients homes, and treatment plans are delivered based on diagnostic results. Operations are led by founder and CEO Daniel Rifkin, serving users across the United States in respiratory health services.
Ognomy's top competitors include Loona, GEM Health and Stellar Sleep.
Ognomy offers Video Consultation Service, Home Sleep Test, and Personalized Treatment Plan.
Ognomy has 7 investors. Key investors include Inspire Medical, Impellent Ventures, Catalyst Investors, Blue Heron Capital, and Launch NY.